Regulation on Gene Diagnosis and Non-Existence of Equilibrium in the Lif/Medical Insurance Market
This study is based on the assumption that in future, genetic testing will create a situation where people can tell whether they are disposed to certain diseases including cancer, but utilization of such genetic testing is banned for the purposes of medical examination of insurants. What, then, would the response of people to genetic testing from an economics perspectives?.
|Date of creation:||Jul 2000|
|Date of revision:|
|Contact details of provider:|| Postal: 2-1 Rokkodai, Nada, Kobe 657-8501 JAPAN|
Phone: +81-(0)78 803 7036
Fax: +81-(0)78 803 7059
Web page: http://www.rieb.kobe-u.ac.jp/index-e.html
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:kob:dpaper:113. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Office of Promoting Research Collaboration, Research Institute for Economics & Business Administration, Kobe University)
If references are entirely missing, you can add them using this form.